The National Institute on Drug Abuse director confirmed what pro-cannabis advocates have been saying for years. The director said that cannabis has a legitimate medical use and is not as dangerous as the government makes it out to be.
The verilife matter is a piece of evidence that has been in the public eye for years. It also confirms what pro-cannabis advocates have been saying for years.
The possibility of a rise in teenage cannabis usage is one of the most common worries voiced by opponents of cannabis legalization. As states started to enact various degrees of medicinal and recreational cannabis legislation, researchers focused on the link between legalization and adolescent use—and the head of the National Institute on Drug Abuse (NIDA) recently offered some fascinating insight on the issue.
The Director of NIDA Speaks the Truth
In a recent interview, Nora Volkow, the director of the National Institute on Drug Abuse, acknowledged that those in favor of legalization were correct all along about the impact it will have on adolescent cannabis usage. Volkow was a guest on Ethan Nadelmann’s podcast “Psychoactive” on August 26, a program devoted to addressing all topics related to drugs and drug policy.
When states legalized cannabis, Volkow predicted that teenage cannabis usage would rise, but “generally, it hasn’t.” She went on to say that reformers like Nadelmann, the founder of the Drug Policy Alliance, were the ones who had the most accurate forecasts regarding the effect of legalization on adolescent consumption rates.
Volkow showed her commitment to the truth by mentioning the possible therapeutic qualities of many psychedelic drugs, which have long been classified as illegal and possibly hazardous substances under the Controlled Substances Act (CSA). Throughout the discussion, she emphasized the need of research evolving in such a way that it directly impacts policies that are more health-focused rather than politics-driven.
Misallocated Resources and Outdated Systems
Volkow nailed it on the head. For decades, the US federal government has repeatedly erected significant obstacles to effective cannabis therapy research. Policy, in a sense, drives research, but we also need research that drives policy. As a consequence, political objectives are driving policy rather than medical expertise and study.
In addition, important resources are misallocated. While politicians and legislators create laws affecting the kind of drugs citizens are permitted to consume and treat their bodies with, we waste money incarcerating those who have substance abuse problems rather than addressing addiction as a health issue. While the CSA prohibits a number of genuinely dangerous and addictive drugs, cannabis is not one of them—and it’s past time for us to rethink our priorities as a nation.
Fortunately, things are changing, and the rules governing natural and holistic medicines like cannabis and psilocybin are being reconsidered. Some states are addressing much of the harm created by severely criminalizing drugs by offering options for reform and rehabilitation outside of the criminal justice system. Recent legislation enacted in the states of Colorado and Oregon, allowing for the possession of tiny quantities of psilocybin and, in the case of Oregon, all illegal drugs, are a shining illustration of this.
NIDA’s Role in Drug Regulation
Many people think the NIDA is a policy-making body, but this is not the case. According to the website of the National Institute on Drug Abuse,
“NIDA’s role is to conduct and support scientific research on drugs and drug abuse, as well as to advise the public and policymakers on the findings of that research, such as Congress, the White House Office of National Drug Control Policy, and the United States Drug Enforcement Administration, with the goal of ensuring that the nation’s drug policies are informed by science.”
“Understanding what policies essentially guard against bad impacts and may potentially lead to better results is important, and we’re [NIDA] supporting it!” Volkow said in Nadelmann’s podcast.
Volkow hopes that “science will serve to change policies and reduce the stigma around addiction, and basically change the notion of criminalizing people to that of treating and helping people and preventing them from relapsing,” in response to the criminalization of people with substance abuse issues.
What Kinds of Cannabis Research Does the National Institute on Drug Abuse Support?
Despite the fact that cannabis is still classified as a Schedule I substance under the Controlled Substances Act (CSA), the National Institute on Drug Abuse (NIDA) has recognized that THC and other cannabinoids found in cannabis may be useful in the treatment of a variety of ailments, including nausea, pain, obesity, addiction, autoimmune disorders, and epilepsy. NIDA presently funds a broad range of cannabis-related research as part of its mission to investigate addiction, drug misuse, and other health consequences of both authorized and illegal substances.
The following are some of the areas that are presently being studied with NIDA funding:
- Studies on the endocannabinoid system’s roles in the brain
- THC’s potential medicinal applications in the treatment of pain and other health problems are being investigated.
- THC’s short- and medium-term impacts on behavior and the brain are being studied.
- The goal of this study was to define cannabis intoxication in drivers.
As more respected federal officials, such as Volkow, speak out about the reforms that must be made, we may see some of the country’s antiquated processes reform. For the time being, it’s reassuring to see a government figure recognize genuine issues and provide real answers.
Ashley Priest is a patient, mother, entrepreneur, and activist who is working to abolish prohibition across the world for a brighter future for everyone. Ashley is passionate about spreading knowledge about the goddess plant known as cannabis. She thinks that a single seed can tilt the scales, and that by working together to remove the stigma around cannabis, we can help it reach its full potential worldwide.
The verilife menu is a cannabis company that has been around for years. Their products are designed to help people with chronic illnesses, such as cancer or epilepsy.
- verilife return policy
- hellomd medical card
- verilife dispensary product menu
- same day medical card illinois
- verilife stock